ALPHATEC HOLDINGS Reports 31.6% YOY Revenue Increase in FY2023 Q3 with USD 118.3 Million in Total Revenue

November 21, 2023

☀️Earnings Overview

On November 6 2023, ALPHATEC HOLDINGS ($NASDAQ:ATEC) reported its earnings results for Q3 of FY2023, showing total revenue of USD 118.3 million, a rise of 31.6% from the same period in the previous year. The company also reported a net income of USD -42.6 million in comparison to the preceding year’s -37.0 million.

Analysis

GoodWhale has conducted an analysis of ALPHATEC HOLDINGS‘s wellbeing, and according to their Star Chart, the company is strong in growth and assets, and weak in profitability and dividend. After further analysis, GoodWhale classified ALPHATEC HOLDINGS as a ‘cheetah’, a type of company that achieved high revenue or earnings growth but is considered less stable due to lower profitability. This type of company may be attractive to investors looking for potentially high returns, but they should be aware of the risks of investing in a company with lower profitability and a low health score of 2/10. In the event of any crisis, the company may not be able to safely ride it out without the risk of bankruptcy. In order to have a higher chance of success, investors should research the company thoroughly and take into account the potential risks. More…

  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Alphatec Holdings. More…

    Total Revenues Net Income Net Margin
    450.24 -173.2 -34.5%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Alphatec Holdings. More…

    Operations Investing Financing
    -61.89 -128.6 206.36
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Alphatec Holdings. More…

    Total Assets Total Liabilities Book Value Per Share
    670.22 714.38 -0.32
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Alphatec Holdings are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    50.1% -35.4%
    FCF Margin ROE ROA
    -30.1% 275.6% -14.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items




  • Peers

    The company’s competitors include Titan Medical Inc, Xtant Medical Holdings Inc, and Modular Medical Inc.

    – Titan Medical Inc ($TSX:TMD)

    Titan Medical Inc is a medical device company that develops, manufactures and sells robotic surgical systems for use in minimally invasive surgery. The company has a market cap of 68.04M as of 2022 and a Return on Equity of -55.6%. Titan Medical Inc’s products are designed to provide surgeons with enhanced visualization, dexterity and access to the surgical site. The company’s products are used in a variety of surgical procedures, including general surgery, urology, gynecology, colorectal surgery and bariatrics.

    – Xtant Medical Holdings Inc ($NYSEAM:XTNT)

    Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development and commercialization of regenerative medicine products and platforms for the treatment of orthopedic injuries and diseases. The company’s product portfolio includes biologic scaffolds, bone graft substitutes, and other regenerative medicine products for use in spine, hip, knee, hand, foot and extremity, and sports medicine procedures. Xtant Medical’s products are sold in over 50 countries worldwide.

    Xtant Medical has a market cap of 69.28M as of 2022 and a Return on Equity of -14.12%. The company is focused on the design, development and commercialization of regenerative medicine products and platforms for the treatment of orthopedic injuries and diseases. Xtant Medical’s products are sold in over 50 countries worldwide.

    – Modular Medical Inc ($NASDAQ:MODD)

    Modular Medical Inc is a healthcare company that provides medical products and services. The company has a market cap of 32.74M as of 2022 and a Return on Equity of -84.42%. Modular Medical Inc’s products and services include medical devices, diagnostic products, and health services. The company operates in the United States, Europe, Asia, and Africa.

    Summary

    ALPHATEC HOLDINGS reported its earnings results for the third quarter of FY2023, with total revenue increasing by 31.6% year-over-year to USD 118.3 million. Net income was USD -42.6 million, which is an improvement over the previous year’s -37.0 million. This suggests that the company is continuing to grow despite the challenging economic environment.

    Investors should note that ALPHATEC HOLDINGS continues to focus on enhancing its product portfolio and expanding its customer base, which could lead to greater returns in the future. Overall, this is a good sign for investors considering an investment in ALPHATEC HOLDINGS.

    Recent Posts

    Leave a Comment